多支动脉桥与单支动脉桥冠状动脉旁路移植术后的长期生存比较
该研究基于SYNTAX Extended Survival研究(SYNTAXES)的随机和注册CABG患者(n=1509),排除仅静脉桥(n=42)或合成桥(n=1)后纳入1466例,比较多支动脉桥(MAG,465例,31.7%)与单支动脉桥(SAG,1001例,68.3%)的长期生存。最长随访12.6年,MAG组全因死亡23.6%,SAG组40.0%,校正后HR 0.74(95%CI 0.55-0.98;P=0.038),敏感性分析证实。三支病变患者中MAG与更低的全因死亡相关(校正HR 0.65,95%CI 0.44-0.97;P=0.033)。
要点
- MAG组12.6年全因死亡低于SAG组(23.6% vs 40.0%,校正HR 0.74,95%CI 0.55-0.98;P=0.038)。
- 三支病变患者中MAG与更低的全因死亡相关(校正HR 0.65,95%CI 0.44-0.97;P=0.033)。
- 左主干病变、合并或不合并糖尿病及SYNTAX评分三分位组中,风险校正后未见显著差异。
核心结论
- 在SYNTAX试验所有 comers 患者的 post hoc 分析中,MAG策略较SAG策略在12.6年随访时全因死亡显著更低。
- MAG相对于SAG的显著长期生存获益鼓励在预期寿命合理的选定患者中更广泛地使用多支动脉桥。
研究设计与样本
- 本研究为SYNTAX Extended Survival研究(SYNTAXES)的 post hoc 分析,纳入随机和注册治疗的CABG患者(n=1509)。
- 排除仅静脉桥(n=42)或合成桥(n=1)患者后,最终纳入1466例,其中MAG 465例(31.7%),SAG 1001例(68.3%)。
- 主要终点为最长随访时的全因死亡,采用多变量Cox回归校正基线特征差异,并使用倾向匹配逆概率治疗权重进行敏感性分析。
主要发现
- 最长随访12.6年时,MAG组全因死亡23.6%,SAG组40.0%,校正HR 0.74(95%CI 0.55-0.98;P=0.038),敏感性分析证实。
- 三支病变患者中,MAG与12.6年时显著更低的全因死亡相关(未校正和校正后均显著;校正HR 0.65,95%CI 0.44-0.97;P=0.033)。
- 左主干病变、合并或不合并糖尿病以及SYNTAX评分三分位组中,风险校正后未见显著差异。
- 接受MAG的患者更年轻且风险更低。
临床怎么用
- 对于预期寿命合理的选定CABG患者,可考虑更广泛地使用多支动脉桥以改善长期生存。
- 在三支病变患者中,MAG策略可能带来更显著的长期生存获益。
局限性
- 本研究为 post hoc 分析,MAG组患者更年轻且风险更低,可能存在选择偏倚。
- 左主干病变、糖尿病亚组及SYNTAX评分三分位组中风险校正后未见显著差异,提示获益可能限于特定人群。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: This study sought to evaluate the long-term differences in survival between multiple arterial grafts (MAG) and single arterial grafts (SAG) in patients who underwent coronary artery bypass grafting (CABG) in the SYNTAX study. METHODS: The present analysis included the randomized and registry-treated CABG patients (n = 1509) from the SYNTAX Extended Survival study (SYNTAXES). Patients with only venous (n = 42) or synthetic grafts (n = 1) were excluded. The primary end point was all-cause death at the longest follow-up. Multivariable Cox regression was used to adjust for differences in baseline characteristics. Sensitivity analysis using propensity matching with inverse probability for treatment weights was performed. RESULTS: Of the 1466 included patients, 465 (31.7%) received MAG and 1001 (68.3%) SAG. Patients receiving MAG were younger and at lower risk. At the longest follow-up of 12.6 years, all-cause death occurred in 23.6% of MAG and 40.0% of SAG patients [adjusted hazard ratio (HR) 0.74, 95% confidence interval (CI) (0.55-0.98); P = 0.038], which was confirmed by sensitivity analysis. MAG in patients with the three-vessel disease was associated with significant lower unadjusted and adjusted all-cause death at 12.6 years [adjusted HR 0.65, 95% CI (0.44-0.97); P = 0.033]. In contrast, no significance was observed after risk adjustment in patients with the left main disease, with and without diabetes, or among SYNTAX score tertiles. CONCLUSIONS: In the present post hoc analysis of all-comers patients from the SYNTAX trial, MAG resulted in markedly lower all-cause death at 12.6-year follow-up compared to a SAG strategy. Hence, this striking long-term survival benefit of MAG over SAG encourages more extensive use of multiple arterial grafting in selected patients with reasonable life expectancy. TRIAL REGISTRATION: SYNTAXES ClinicalTrials.gov reference: NCT03417050; SYNTAX ClinicalTrials.gov reference: NCT00114972.
引用
- Thuijs DJFM, Davierwala P, Milojevic M, et al. Long-term survival after coronary bypass surgery with multiple versus single arterial grafts. Eur J Cardiothorac Surg. 2022. PMID: 34618017. doi:10.1093/ejcts/ezab392
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。